CHRISTOPHER J COUGHLIN
CIK 1110750 · EVP and CFO · last filed 2026-05-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.55M
Companies
14
Total Filings
198
Lifetime Open-Market Net
$2.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTE | Director | 48,202 | — | — | $1.50M | 25 | 2026-05-13 |
| CNC | Director | 14,156 | $65.19 | $922.9K | $0 | 1 | 2026-03-31 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Director | 0 | $329.83 | $0 | $0 | 6 | 2024-03-18 |
| PBH | Director | 13,218 | $47.82 | $632.1K | $0 | 4 | 2022-08-03 |
| Allergan plc (AGN) Delisted | Director | 16,542 | — | — | $1.91M | 6 | 2020-05-11 |
| Allergan plc (AGNpA) Delisted | Director | 14,446 | — | — | $1.63M | 8 | 2017-12-05 |
| DUN & BRADSTREET CORP/NW (DNB) Delisted | Director | 17,335 | $9.15 | $158.6K | -$740.5K | 76 | 2017-03-13 |
| HOLOGIC INC (HOLX) Delisted | Director | 5,427 | $76.01 | $412.5K | $0 | 2 | 2017-03-09 |
| Allergan plc (ACTpA) Delisted | Director | 2,000 | — | — | $0 | 1 | 2015-06-08 |
| Covidien plc (COV) Delisted | Director | 58,032 | — | — | $0 | 5 | 2014-03-21 |
| PLx Pharma Inc. (DPRX) Delisted | Director | 109,309 | — | — | $25.0K | 1 | 2014-03-20 |
| Forest Laboratories, LLC (FRX) Delisted | Director | 3,933 | $12.00 | $47.2K | $0 | 3 | 2013-08-16 |
| Covidien plc (COVw) Delisted | Director | 55,272 | — | — | -$2.23M | 31 | 2013-05-07 |
| Johnson Controls International plc (TYC) Delisted | EVP and CFO | 88,558 | — | — | $0 | 7 | 2010-11-30 |
Recent Filings · Page 3 of 20
198 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-04 | CNTE | Grant (A) | +510 | $0 | EDGAR |
| 2023-01-05 | Karuna Therapeutics, Inc. (KRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-04 | CNTE | Grant (A) | +443 | $0 | EDGAR |
| 2022-10-04 | CNTE | Grant (A) | +405 | $0 | EDGAR |
| 2022-08-03 | PBH | Grant (A) | +2,495 | $0 | EDGAR |
| 2022-07-05 | CNTE | Grant (A) | +436 | $0 | EDGAR |
| 2022-06-16 | Karuna Therapeutics, Inc. (KRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-03 | CNTE | Buy (P) | +12,000 | $976.4K | EDGAR |
| 2022-04-28 | CNTE | Grant (A) | +2,323 | $0 | EDGAR |
| 2022-04-04 | CNTE | Grant (A) | +441 | $36.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.